Tuesday, 11 September 2018

Global Sacroiliitis Market Overview - Key Futuristic Trends and Opportunities

Market Scenario
The global sacroiliitis market is expected to witness growth during the forecast period. Sacroiliitis is a medical condition where there is inflammation in one or both sacroiliac joints situated in the pelvis and lower back. The function of a sacroiliac joint is to bear the weight of the upper body while standing, walking, and others. The condition can be diagnosed by imaging techniques. Sacroiliitis is caused due to traumatic injury, arthritis, pregnancy, infection, spondylitis, and others. The increasing prevalence of arthritis is the key factor for the market growth. According to the Centers for Disease Control and Prevention (2013to 2015), 22.7% Americans of the total population had arthritis, annually. Thus, such a high prevalence of arthritis and increasing government funding for the healthcare sector enhance the growth of this market.
However, factors such as expensive diagnostic tests and the high cost of surgical procedures are expected to restrict the market growth during the forecast period.
Segmentation
The global sacroiliitis market is segmented on the basis of diagnosis, treatment, and end-user. The sacroiliitis market, by diagnosis, is sub-segmented into imaging tests and anesthetic injections. The imaging tests category includes x-ray, MRI, and CT scan. On the basis of treatment, the market is categorized into medications, joint injections, radiofrequency denervation, electrical stimulation, joint fusion, facet block, chiropractic manipulation, and physical therapy. On the basis of end-user, the market is segmented into hospitals and clinics, pharmacies, and diagnostic centers.
On the basis of region, the global sacroiliitis market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.
Key players
Some of the key players in the global sacroiliitis market are Medacta International, SI-BONE, Globus Medical, Zyga Technology, Nutech Medical, CoorsTek Medical LLC, Aspen Medical Products, Medtronic, and others.
Regional Market Summary
The sacroiliitis market is dominated by North America owing to the high prevalence of arthritis and high healthcare investments within this region. According to the Centers for Disease Control and Prevention by 2040, 78.4 million will have doctor-diagnosed arthritis.
The rising adoption of technologically advanced systems for early diagnosis of diseases also drives the market growth in this region.
It is estimated that Europe stood second in the global sacroiliitis market. The increasing prevalence of lower back disorders and the availability of minimally invasive surgical procedures for sacroiliitis drive the market growth in this region. According to The European (2015), sacroiliac joint was the main reason for chronic low back pain in Europe.
Asia-Pacific was projected to be the fastest growing region for the global sacroiliitis market. Key factors such as the growing patient pool, the high prevalence of chronic diseases, developing healthcare infrastructure, and increasing research and development activities in the biotechnology sector influence the market in this region. The presence of major market players such as China, India, and Japan drives the market growth.
The Middle East and Africa holds the least share of the global sacroiliitis market due to the presence of stringent government policies and poor economies. However, growing awareness among the population, rising government initiatives to improve the healthcare sector, and high investments by private market players in this region can boost the market growth. 
Detailed Table of Contents:
Table Of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
...Continued

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Healthcare Asset Management Market 2018 World Analysis and Forecast to 2023

Market Scenario
The healthcare asset management market is expected to grow during the forecast period (2018–2023) at a CAGR ~18.2%.
Healthcare asset management uses applications such as Radiofrequency Identification (RFID) and plays an important role in optimization and effective use of medical devices, managing inventory and reducing human error. The growing concern for patient safety, need to increase the efficiency of available resources, and acceptance of advanced technology in the healthcare sector are expected to drive the growth of the market. Moreover, rising R&D spending and strategies applied by major players such as new product development are contributing to the growth of the market. For instance, in August 2018, Infor Inc. which is a major player in the healthcare asset management sector announced the latest version of Enterprise Asset Management (EAM) software.
The rising concerns about patient safety, accuracy issues with the devices, the high installation cost of healthcare asset management tools, and poor implementation due to organizational and infrastructure issues may hamper the growth of the market during the assessment period.
Segmentation
The healthcare asset management market has been segmented on the basis of product, application, and end-user.
On the basis of product, the market has been classified as real-time location systems (RTLS), radiofrequency identification (RFID) devices and ultrasound & infrared tags. The real-time location systems (RTLS) segment has been further divided into hardware, software and services. The hardware segment has been further divided into tags/badges and readers/interrogators.
The radiofrequency identification (RFID) devices have been classified as hardware, and software and services. the hardware segment has been divided tags, readers/interrogators, and accessories. The tags sub-segment has been segmented into passive tags and active tags. The passive tags segment has been divided into high-frequency (HF) tags, ultra-high-frequency (UHF) tags and low-frequency (LF) tags. Furthermore, the application segment has been sub-segmented into hospital asset management and pharmaceutical asset management. The hospital asset management segment includes equipment tracking and management, patient management, temperature and humidity monitoring, staff management and infection control and hand hygiene compliance. The pharmaceutical asset management segment includes drug anti-counterfeiting and supply chain management.
The market, by end-user, has been segmented into Hospital/Clinic, Laboratories, Pharmaceutical companies, Biotechnology.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The healthcare asset management market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European healthcare asset management market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 
The healthcare asset management market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The healthcare asset management market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Market Summary
The Americas are likely to dominate the healthcare asset management market owing to the adoption of highly advanced technology, increasing demand for new technology to stop fake drugs(Drug counterfeiting) and the presence of a well-established healthcare system as well as the presence of a huge network of healthcare service providers. According to the American hospital association, in the year 2016, a number of registered hospitals in the US was 5,534, roughly 2000 hospitals were present in the rural area and 3000+ hospitals were operating in the urban area.
The European market is expected to be the second-largest healthcare asset management market. The market growth in this region can be attributed to government funding and support of the healthcare sector coupled with increasing research and development. Moreover, increasing cases of drug counterfeiting is responsible for rising demand for healthcare asset management services and it is also contributing to the growth of the market in this region. According to the European intellectual property office drug, the counterfeit is a major problem in the healthcare sector. Revenue of USD 11.5 billion is lost per year because of drug counterfeiting and 10% of all medicines supplied globally are falsified.
Asia-Pacific is expected to be the fastest-growing healthcare asset management market during the forecast period owing to the increasing demand for easy to use asset management software’s, increasing digitalization in the region, and investments in healthcare and expansions by market players in the region.
The market in the Middle East & Africa is expected to account for the smallest share of the healthcare asset management market due to an underdeveloped healthcare sector, poor medical facilities and lack of technical knowledge
Key Players
Some of the key players in the healthcare asset management market are cenTrak, Airista Flow, GE Healthcare, IBM Corporation, Infor Inc., Tyco Security Products., Intelligent InSites, Motorola Solutions, Inc., Radianse, JADAK (a Novanta Company), Siemens Healthineers, Sonitor Technologies, Stanley Black & Decker, Inc., Ekahau, Inc.
Detailed Table of Contents:
Table Of Content
  1. Report Prologue
  2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
  1. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
  1. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
  1. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry

...Continued

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Global Anal Fissure Treatment Market Trends, Demand and Forecast to 2023

The global anal fissure treatment market is expected to attain USD 2.6 Bn and capture a CAGR of 5.2% over the forecast period of 2017-2023. An anal fissure is a painful medical condition where the anal canal has been torn and is accompanied by pain and bleeding during and after defecation. There has been a steep rise in the incidence of anal fissures which is, in turn, propelling the market for anal fissure treatment. The anal fissure market is primarily driven by growing prevalence of constipation, diarrhea, tuberculosis, carcinoma, acquired immunodeficiency syndrome (AIDS), and inflammatory bowel disease, etc. The rise in the geriatric population who are at a higher risk of developing anal fissures owing to decreased blood flow to the anus is also a chief driver of the market. Bad eating habits, leading to stressful and hectic life, and sedentary lifestyle observed among all age groups are even driving the market for anal fissure treatment.
Segments:
The global anal fissure treatment market is segmented on the basis of drugs and surgery. Based on drugs, the market has been segmented as topical nitroglycerin, calcium channel blockers, stool softeners, and others. Based on the surgery, the market has been segmented as lateral internal sphincterotomy, anal dilation and others.
Regional analysis
US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. The faster market uptake of new technology in the US is also an important driver of the market for global anal fissure treatment. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is the fastest growing region because of large unmet needs which is led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa are expected to be a laggard due to poor economic and political conditions and poor healthcare penetration.
Regional Analysis
The key markets of the global anal fissure treatment market are North America, Europe, Asia-Pacific, and the Middle East & Africa. Asia-Pacific is estimated to lead the market owing to unmet medical needs of a large population pool and falling prices of anal fissure treatment, growing number of hospitals and increased expenditure on healthcare due to rise in disposable income in the region. The US accounts for a significant share of the market due to favorable reimbursement landscape and advancement in the field of healthcare technology in the region. The Gulf nations mainly Saudi Arabia and UAE are the major contributors of the Middle East and Africa market. However, the economically and socially backward regions of Africa are expected to exhibit staggered growth owing to low penetration of healthcare facilities in the region.
Competitive Landscape
The key players operating in the market include SRS Pharmaceuticals Pvt. ltd., Takeda Pharmaceutical Company Limited, Novasep, PurduePharma L.P., Healthy Life Pharma Private Limited, Troikaa Pharmaceuticals Ltd., Taj Pharmaceuticals Ltd., Geri-Care Pharmaceuticals, and others.
Detailed Table of Contents:
  1. Introduction
1.1 Definition
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure:
  1. Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research:
  1. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
  • Macroeconomic Indicators
  1. Conclusion
10.1 Key Findings
10.1.1 From Ceo’s Viewpoint
10.1.2 Unmet Needs Of The Market
10.2 Key Companies To Watch
10.3 Prediction Of Anal Fissure Treatment Industry
  1. Appendix
...Continued
         
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Monday, 10 September 2018

Dyspepsia Market Expected to Grow at High Cagr during Forecast Period 2018 – 2023

Market Scenario
The global dyspepsia market is expected to witness a positive growth during the forecast period. Dyspepsia is a chronic medical condition, that causes discomfort in the upper abdomen of the patient due to indigestion. The gastrointestinal organs, the stomach and the small intestine (sometimes the esophagus), do not function normally. Gastrointestinal causes of dyspepsia are gastritis, peptic ulcers, gallstones, stomach cancer, constipation, reduced blood flow in the intestine (intestinal ischemia). Nongastrointestinal causes are diabetes, thyroid disease, kidney disease and consumption of drugs like nonsteroidal anti-inflammatory drugs (NSAIDs such as ibuprofen), antibiotics and others. Dyspepsia is also caused due to overeating, smoking and extreme consumption of alcohol. Increasing prevalence of digestive diseases is the key factor for the market to grow. According to the Centers for Disease Control and Prevention in 2016, 14.7 million people in the US suffered from digestive ulcers. Such a high prevalence of digestive diseases enhances the market growth during the forecast period. Other factors like growing caffeine intake, increasing alcohol consumption, rising prevalence of diabetes, increasing incidences of thyroid diseases and stomach cancer, robust R&D activities to develop new drugs and advancement in diagnosis and treatment technologies is driving the growth of the market.
However, factors such as expensive diagnosis test and intense competition among the major market players to gain maximum market share are expected to restrict the market growth during the forecast period.
Segmentation
The global dyspepsia market is segmented on the basis of diagnosis, treatment, and end-user. The dyspepsia market, by diagnosis, is sub-segmented into blood tests, breath tests, stool tests, endoscopy, X-ray, CT scan, and others. On the basis of treatment, the market is categorized into antacids, antibiotics, h2 blockers, proton pump inhibitors (PPIs), prokinetics, psychological therapies and others. Antacids are further sub-segmented into calcium carbonate, loperamide, simethicone, sodium bicarbonate and others. Antibiotics further sub-segmented into amoxicillin, clarithromycin,  metronidazole, and others. H2 blockers are further categorized into cimetidine, famotidine, nizatidine, ranitidine, and others.  Proton pump inhibitors (PPIs) is further segmented into esomeprazole, lansoprazole, and omeprazole. Prokinetics are categorized into bethanechol and metoclopramide. On the basis of end-user, the market is segmented into hospitals and clinics, ambulatory surgical centers, pharmacies, diagnostic centers and others.
On the basis of region, the global dyspepsia market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and South America. The North American region is further segmented into the U.S. and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the U.K., Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.
Key players
Some of the key players for the global dyspepsia market are AstraZeneca, GlaxoSmithKline, Takeda Pharmaceutical Company, Johnson & Johnson, Eisai Co., Ltd., Abbott Laboratories, Salix Pharmaceuticals, Bayer AG, Boehringer Ingelheim GmbH, Sanofi, Allergan Plc, and others.
Regional Market Summary 
The dyspepsia market is dominated by North America owing to rising prevalence of ulcerative colitis.
Ulcerative Colitis causes inflammation of the digestive tract which may lead to dyspepsia. According to the Centers for Disease Control and Prevention in 2015, 3 million people suffered from ulcerative colitis. Also, the increased adoption of technologically advanced devices and the high amount of healthcare expenditure drives the market growth in this region.
It is estimated that Europe stood second in the global dyspepsia market. Thus, increasing prevalence of chronic digestive disease in Europe contributes to market growth. According to the United European Gastroenterology report published in 2018, 365,000 deaths in Europe were due to digestive cancers. Also, rising healthcare expenditure and R&D activities are driving the growth of this market in Europe.
Asia-Pacific was projected to be the fastest growing region for the global dyspepsia market. Key factors such as rising number of patient population, increase in the adoption of minimally invasive surgeries, and rapid rise in endoscopy for the diagnosis and treatment of digestive diseases, influences the market in this region. Also, the rising medical tourism in countries like Malaysia, India, and Thailand drives market growth in this region.
The Middle East and Africa holds the least share of the global dyspepsia market due to the presence of stringent government policies and poor economies. However, increasing investment by private market players and growing government initiatives in this region can boost the market growth.
Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/6351    
TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry

       
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Posted by at No comments:

Friday, 7 September 2018

Cardiac surgery Instruments Market to Observe Strong Development by 2018

Market Scenario:
Cardiac surgery instruments are specially designed tools that are being used for performing specific actions during the heart related surgery or operation to derive desirable effect. These tools are designed according to use of it, some surgical instruments are used in general surgery while some are designed for specific surgery or operation. Increasing number of heart diseases and cardiac surgery are driving the growth for cardiac surgery instruments market. Growing healthcare sector and increasing number of hospitals are key drivers for the market. Surgical instruments manufacturers are developing new and innovative tools for the market. These instruments are essential for all the hospitals and one of the essential growth factor for the market. Cardiac surgery instrument market is growing moderately. The global Cardiac surgery instruments market in 2015 was about US$ 1.1 billion and expected to reach US$ 1.75 billion at CAGR of 6.9% by 2023.
Market Dynamics:
Increasing Number Of Cardiac Surgeries Is The Prime Driver Of The Market Growth
Increasing number of heart diseases and cardiac surgery, growing healthcare sector and increasing number of hospitals is the prime driver of the market. According to the World Health Organization estimates, in 2015 alone over 17.7 million people representing 31% of all global deaths expired due to complications arising due to cardiovascular diseases. The World Health Organization further states that 82% of the total deaths occurred were in the low- and middle-income countries. Additionally, the Centers for Disease Control and Prevention have said that in 2015, over 630,000 Americans died from heart disease-related issues, resulting in 1 in every 4 deaths.
Favorable Reimbursement Policies Coupled With The Growth In Risk Factors Will Drive A Significant Demand
Other drivers of the market are favorable reimbursement policies, increasing the prevalence of cardiovascular diseases and rising healthcare expenditure are constraining the market. The growth in risk factors such as increasing geriatric and diabetes population, sedentary lifestyles, high intake of fat-rich foods and others are indirectly driving the market. In the latest study conducted by World Health Organization, approximately 422 million people had diabetes in 2015. As per the National Diabetes Statistics Report suggested by Centres for Disease Control and Prevention, it is found that 9.4% of the U.S. population, i.e. 30.3 million people had diabetes in 2015.
Growing Stringency Of Regulations May Hamper The Market
The growing stringency of FDA regulations and uncertainty of healthcare policies in the U.S are significant constraints on the market. The poor per capita income of the underdeveloped economies of the world and the poor healthcare expenditure are dragging the market.
Dominant Players:                                
Some of the key players operating in the market are Johnson & Johnson Services, Inc. (US), DEALMED MEDICAL SUPPLIES LLC (US), Stryker (US), B. Braun Melsungen AG (Germany), STILLE (Sweden),  MedServ International (Germany), Delacroix-Chevalier (France), SIM Surgical (US), Gebrüder Martin GmbH & Co. KG (Germany), Surtex Instruments Limited (UK) and others.
Segments:                                                                                                                                        
To generate an accurate assessment of the global cardiac surgery Instruments market, the report is segmented by type
Based on the type, the market is segmented by forceps, graspers, clamps, scissors, retractors, spreaders, graspers, and others. Based on application, the market is segmented by coronary artery bypass grafting (CABG), valve repair or replacement, aneurysm repair, heart transplant, and others.
Based on the type of material, the market is segmented into stainless steel, tungsten carbide, and others. Based on end user market is segmented into hospitals and ambulatory surgery centers. Based on regions, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa.
Table of Contents:
1. Report Prologue
2. Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
List of Tables and Figures:
List Of Tables
Table 1 Global Cardiac Surgery Instruments Market, By Type
Table 2 Global Cardiac Surgery Instruments Market, By Application
Table 3 Global Cardiac Surgery Instruments Market, By Type Of Material
Table 4 Global Cardiac Surgery Instruments Market, By End User
Table 5 Global Cardiac Surgery Instruments Market, By Region
List Of Figures
Figure 1 Research Process
Figure 2 Porters Five Forces Model
Figure 3 Global Cardiac Surgery Instruments Market, By Type
Figure 4 Global Cardiac Surgery Instruments Market, By Application
Figure 5 Global Cardiac Surgery Instruments Market, By Type Of Material
Figure 6 Global Cardiac Surgery Instruments Market, By End User
...Continued

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Influenza Diagnostics Market Revenue, Opportunity, Forecast and Value Chain 2018

Global Influenza Diagnostics Market is growing moderately. Influenza or flu is one of the common medical condition which occur in seasonal epidemics and shows an acute illness with variable degrees of systemic symptoms which ranges from mild fatigue to respiratory failure and death. Influenza B is most common type of flu. Influenza infection can create health complications which may be deadly, but early diagnosis of influenza can reduces the chances of further complications. According the World Health organization, there are almost 600 million cases of influenza worldwide. The increasing demand for advanced diagnostic products and kits, increasing R&D funding for new innovative products and increasing healthcare expenditure are major driving factors for this market. The Global Influenza Diagnostics market is expected to reach US$ 700.7 million by 2023 and is projected to grow at the CAGR of ~5.8% during the forecast period from 2017-2023.
Market Research Future (MRFR) has published a report about the global influenza diagnostics market. This report expects 5.8% CAGR during the forecast period between 2017 and 2023. In terms of cash, this market is expected to grow with US $ 700.7 mn by 2023. This report analyzes the market, potential for growth during the forecast period, market sizes around the world, key players in the market, product launches and latest research and development (R&D). The global influenza diagnostics market is on the basis of types, tests, and region. The segmentation of types comprises of type A flu, type B flu, type C flu. The three forms of type A are bird flu, seasonal flu, and Swine flu. On the basis of direct fluorescent antibody (DFA) tests, molecular tests, nucleic acid sequence-based amplification (NASBA) tests, rapid influenza detection tests (RIDT), serological assays, simple amplification-based assays (SAMBA) and loop-mediated isothermal amplification-based assays (LAMP). Serological assays are segmented into primary serological tests, secondary serological tests, and tertiary serological tests. Primary serological tests cover enzyme-linked immunosorbent assay (ELISA), immunofluorescent antibody technique (IFAT) and radioimmunoassay (RIA). Secondary Serological tests include agglutination tests, complement fixation tests (CFT), precipitation tests, serum neutralization tests (SNT) and toxin-antitoxin test.
Key Players for Global Influenza Diagnostics Market:                               
Some of the key players in this market are: Alere (US), BD (US), Becton, Dickinson and Company (U.S.), Cepheid (US), bioMérieux SA (France), Hardy Diagnostics(us), LifeSign LLC.(US), Meridian Bioscience, Inc.(US), Quidel Corporation (US), Roche Molecular Systems Inc.(Switzerland), Sekisui Diagnostics (US)
Segments:                                                                                                                                        
Global Influenza Diagnostics Market has been segmented on the basis of type of flu which comprise Type A flu (Seasonal flu, Swine Flu, Bird Flu), type B flu, Type C flu. On the basis of type of test it segmented into Molecular Tests, Rapid Influenza Detection Tests (RIDT), Direct Fluorescent Antibody (DFA) Tests, Nucleic Acid Sequence-based Amplification (NASBA) Tests, Serological Assays, Simple Amplification-based Assays (SAMBA), Loop-mediated Isothermal Amplification-based Assays (LAMP), and Others. Serological assays further sub segmented into Primary Serological tests (Enzyme linked immunosorbent assay (ELISA), Immuno fluorescent antibody technique (IFAT), Radio immuno assay (RIA), Secondary Serological tests (Agglutination tests, Complement fixation tests (CFT), Precipitation tests, Serum neutralization tests (SNT), Toxin-antitoxin test), and Tertiary serological tests.
Regional Analysis of Global Influenza Diagnostics Market:                  
Considering the global scenario of the market, North America is believed to be the largest market for Global Influenza Diagnostics due to advanced healthcare facilities and increasing presence of major players in this region. Moreover, the European market second largest market for Global Influenza Diagnostics. In Europe, Western Europe accounts the largest market share. While Asia-Pacific is expected to grow at significant rate in the Global Influenza Diagnostics market during the forecasted period. Middle East and Africa is likely to have a limited growth in the market due to less awareness of these therapies and treatment.  
Detailed Table of Contents:
  1. Report Prologue
  2. Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation
  1. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
  1. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Mega Trends
4.5 Macroeconomic Indicators
  1. Market Factor Analysis
5.1 Value Chain Analysis
5.2 Porters Five Forces
5.3 Demand & Supply: Gap Analysis
5.4 Pricing Analysis
5.5 Investment Opportunity Analysis
...Continued
         
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Digital Wound Measurement Devices Market Expected to Boost during 2018 To 2023

Market Scenario
The global digital wound measurement devices market is expected to witness a positive growth during the forecast period. Digital wound measurement devices enable monitoring of chronic wounds and deliver the appropriate drug dose to speed up the process of healing. Chronic wounds if not treated on time can lead to severe infections and amputations. Hence, digital wound measurement devices allow delivering tailored treatments after the 2D or 3D assessment of the infection and inflammation. The increasing number of patients suffering from chronic wounds drives the market growth. According to the Intermountain Healthcare (2017), 6.5 million people in the US suffer from chronic wounds. Diabetic wounds are severe, and the process of healing is very long and eventually may lead to amputations. Hence factors such as growing diabetic patients, rising geriatric population, and an increasing number of surgeries are major factors influencing the growth of the market. The emergence of smartphones, rapid use of advanced digital tools, and the advent of telehealth for wound care will also contribute for the market to grow.
However, factors such as, the inability of the device to provide additional information about wounds such as moistness or exudation and high costs of digital devices are expected to restrict the market growth during the forecast period.
Segmentation
The global digital wound measurement devices market is segmented on the basis of wound type, product, and end-user. The digital wound measurement devices market, by wound type is sub-segmented into a diabetic ulcer, chronic wounds, burns, incisional, and traumatic. The product segment is sub-segmented into contact wound measuring devices and non-contact wound measuring devices.
On the basis of end-user, the market is segmented into hospitals, clinics, and ambulatory surgical centers.
On the basis of region, the global digital wound measurement devices market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.
Key players
Some of the key players for the global digital wound measurement devices market are WoundRight Technologies Tissue Analytics, Parable Health, ARANZ Medical Limited, eKare, Inc, KCI, an Acelity Company, WoundMatrix, Inc., WoundZoom Inc., Kent Imaging Inc., WoundRight Technologies, LLC, WoundVision, LLC, Hitachi Healthcare Americas, and Smith & Nephew plc.
Regional Market Summary

The digital wound measurement devices market is dominated by North America owing to the rising prevalence of chronic wounds and technological advancements in the healthcare sector.  In June 2018, KCI, an Acelity Company announced the launch of Nurse2Nurse (N2N) Mobile App for wound care nurses. The app allows interactions with clinicians and shares credible insights and information for better patient care.
It is estimated that Europe was the second largest in the global digital wound measurement devices market. The increasing technological advancement and research for wound care along with government support in Europe drive the market growth in this region. The European Wound Management Association will conduct its 29th conference by June 2019 in Gothenburg, Sweden in the presence of several international wound management communities with the common goal of improving the care of wound patients.
Asia-Pacific was projected to be the fastest growing region for the global digital wound measurement devices market. Key factors such as rising geriatric population, growing diabetic patient pool, high incidence chronic wounds, and developing healthcare infrastructure drive the market in this region. According to the Asian Diabetes Prevention Initiative, 60% of the world diabetic population is in Asia. This provides favorable backgrounds for the market to grow in Asia.
The Middle East and Africa holds the least share of the global digital wound measurement devices market due to the presence of stringent government policies and poor economic growth. However, growing awareness and increasing investments by private market players in this region can boost the market growth. 
Detailed Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
...Continued
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Subscribe to: Posts (Atom)